مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

333
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

119
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

1

Information Journal Paper

Title

CERVICAL PRIMING BY MISOPROSTOL BEFORE DIAGNOSTIC DILATATION AND CURETTAGE: A RANDOMIZED CLINICAL TRIAL

Pages

  162-166

Abstract

 Background: Difficulty in cervical DILATATION is a hard situation during the procedure of diagnostic DILATATION and CURETTAGE in some cases. This study was performed to evaluate the effect of vaginal MISOPROSTOL for cervical priming before diagnostic DILATATION and CURETTAGE.Methods: In this study 56 women were selected as the candidates for DILATATION and CURETTAGE. The study was double blind and was performed for two parallel groups. One MISOPROSTOL tablet (200 mg) was administered in posterior fornix of vagina 2-4 hr before operation in 28 patients whereas in other 28 patients, placebo (VitB6) was used. Then, the two groups were compared according to the patency of the cervix measured by No.5 Hegar dilators and the duration of DILATATION and CURETTAGE procedure as well. Chi-square test, t-test, and Mann-Whitney U test were used for comparing two groups, and a p-value less than 0.05 was considered as statistically significant.Results: Before the procedure of DILATATION and CURETTAGE, the patency of the cervix was measured by passing Hegar dilator number 5 through the cervical canal in fifteen (53.6%) patients in the MISOPROSTOL group and 8 patients (28.6%) in the placebo group (p=0.05) which their difference was statistically significant. The effect of MISOPROSTOL was not significant in nulliparous women and postmenopausal period either.Conclusion: Vaginal MISOPROSTOL is a useful drug for ripening and dilating the cervix. It also facilitates the procedure of DILATATION and CURETTAGE in premenopausal and multiparous women. MISOPROSTOL was less effective in nulliparous women and in postmenopausal period.

Cites

References

Cite

APA: Copy

MOHAMMADIAN, SHIMA, TAVANA, ANAHITA, TAVANA, SHAHRZAD, MOHAMMADIAN, AIDA, & FALLAHIAN, MASOUMEH. (2015). CERVICAL PRIMING BY MISOPROSTOL BEFORE DIAGNOSTIC DILATATION AND CURETTAGE: A RANDOMIZED CLINICAL TRIAL. JOURNAL OF REPRODUCTION AND INFERTILITY, 16(3), 162-166. SID. https://sid.ir/paper/648444/en

Vancouver: Copy

MOHAMMADIAN SHIMA, TAVANA ANAHITA, TAVANA SHAHRZAD, MOHAMMADIAN AIDA, FALLAHIAN MASOUMEH. CERVICAL PRIMING BY MISOPROSTOL BEFORE DIAGNOSTIC DILATATION AND CURETTAGE: A RANDOMIZED CLINICAL TRIAL. JOURNAL OF REPRODUCTION AND INFERTILITY[Internet]. 2015;16(3):162-166. Available from: https://sid.ir/paper/648444/en

IEEE: Copy

SHIMA MOHAMMADIAN, ANAHITA TAVANA, SHAHRZAD TAVANA, AIDA MOHAMMADIAN, and MASOUMEH FALLAHIAN, “CERVICAL PRIMING BY MISOPROSTOL BEFORE DIAGNOSTIC DILATATION AND CURETTAGE: A RANDOMIZED CLINICAL TRIAL,” JOURNAL OF REPRODUCTION AND INFERTILITY, vol. 16, no. 3, pp. 162–166, 2015, [Online]. Available: https://sid.ir/paper/648444/en

Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button